Fintel reports that on October 30, 2025, Cantor Fitzgerald maintained coverage of Vanda Pharmaceuticals (NasdaqGM:VNDA) with ...

Fintel reports that on October 30, 2025, Piper Sandler maintained coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a ...

Nearly 42 million people are set to lose food aid due to the second-longest U.S. government shutdown, as Democrats and ...

The investment seeks to track the performance of the ICE U.S. Treasury Inflation Linked Bond Index. The index measures the performance of U.S. dollar denominated sovereign debt publicly issued by the ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

How a US SOL ETF could shift access, flows and usage — plus the key metrics to watch to see whether Solana outperforms Ether. ETH ETFs have opened access, but flows remain cyclical. SOL’s plumbing is ...

Global stocks are at record highs, but positioning data from JPMorgan Chase & Co. suggests some investors including hedge funds are still holding back. “One group of investors that still appear to be ...

Forbes contributors publish independent expert analyses and insights. I write articles about Thailand's financial markets and economy. This story is part of Forbes’ coverage of India’s Richest 2025.

As President Donald Trump's escalating tariff policies threaten to raise costs across global supply chains, one pharmaceutical giant is taking steps to protect its bottom line. On ...

View post: Stock Market Today: Nasdaq Composite, S&P 500 Hit Records After Delayed Inflation Report Arrives Softer Than Expected ...